Cargando…
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial
OBJECTIVES: PRIMARY OBJECTIVE: To determine whether chemoprophylaxis with hydroxychloroquine versus placebo increases time to contracting coronavirus disease 2019 (COVID-19) in frontline healthcare workers. SECONDARY OBJECTIVES: 1. To determine whether chemoprophylaxis with daily versus weekly dosin...
Autores principales: | McEniery, Carmel M., Fisk, Marie, Miles, Karen, Kaloyirou, Fotini, Vamvaka, Evangelia, Hubsch, Annette, Smith, Jane, Wilkinson, Ian B., Cheriyan, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330261/ https://www.ncbi.nlm.nih.gov/pubmed/32616067 http://dx.doi.org/10.1186/s13063-020-04543-4 |
Ejemplares similares
-
Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial
por: McEniery, Carmel M., et al.
Publicado: (2020) -
Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study
por: Cacciottolo, Paul J, et al.
Publicado: (2021) -
Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?
por: Manjunath, B.G., et al.
Publicado: (2020) -
Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
por: Patrì, Angela, et al.
Publicado: (2020) -
Lax equations and quantum groups
por: Maillet, J M
Publicado: (1990)